TrueTicker

NIFTY 500 › Healthcare

Healthcare · NIFTY 500

Mankind Pharma Ltd.

MANKIND on NSE · 19 Nov 2026

NIFTY 500 F&O

2,629.00 ▲ +0.15 % on the day

Overview Technical Risk & rank Results Accounts Filings Options Guidance & governance

Quarterly results

The last 12 quarters, and the day after each.

QuarterRevenueYoYProfitYoYMarginEPSResult dateNext-day move
Q2 FY27 (Jul-Sep 2026)4,338+17.3 % 711+39.1 %16.4 %17.23 26 Oct 2026+8.2 %
Q1 FY27 (Apr-Jun 2026)4,031+12.9 % 568+29.6 %14.1 %13.76 30 Jul 2026-4.1 %
Q4 FY26 (Jan-Mar 2026)3,443- 554-16.1 %13.44 19 May 2026+3.7 %
Q3 FY26 (Oct-Dec 2025)3,567+10.4 % 409+7.5 %11.5 %9.90 03 Feb 2026-3.4 %
Q2 FY26 (Jul-Sep 2025)3,697+20.2 % 512-21.7 %13.8 %12.39 06 Nov 2025-2.0 %
Q1 FY26 (Apr-Jun 2025)3,570+23.4 % 438-18.3 %12.3 %10.62 31 Jul 2025-0.0 %
Q3 FY25 (Oct-Dec 2024)3,230+23.9 % 380-16.2 %11.8 %9.45 24 Jan 2025-4.9 %
Q2 FY25 (Jul-Sep 2024)3,077+13.6 % 653+30.4 %21.2 %16.31 05 Nov 2024+1.3 %
Q1 FY25 (Apr-Jun 2024)2,893+12.2 % 536+10.2 %18.5 %13.39 31 Jul 2024-1.2 %
Q4 FY24 (Jan-Mar 2024)2,441+18.9 % 471+65.1 %19.3 %11.76 15 May 2024-4.5 %
Q3 FY24 (Oct-Dec 2023)2,607- 454-17.4 %11.33 31 Jan 2024+2.3 %
Q2 FY24 (Jul-Sep 2023)2,708- 501-18.5 %12.51 31 Oct 2023+0.1 %

₹ cr, consolidated; EPS in ₹ a share, as reported. YoY: against the same quarter last year. Next-day move: the share's move on the first trading day after the result. A dash means the figure is not available; nothing is estimated.

Financial years

The years these quarters add up to.

Year to MarchRevenueYoYProfitYoYMarginEPS
FY2614,278- 1,913-13.4 %46.35
FY2410,335- 1,913-18.5 %47.75

A year is the sum of its four reported quarters, shown only when all four are available; it can differ a little from the audited annual figures. Results start from Q4 FY23 (Jan-Mar 2023).

Ask Sensei

Ask Sensei

Ask about any NIFTY 500 company in plain words. The answer comes from its own filings, with the page behind every point.

For example:

See a sample answer

Start free Sign in